Superworth

Iridex EPS IRIX

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jul 4, 2026
−$0.20
Latest quarter, Q2 FY26
−$0.07
Fiscal year 2025
−$0.26

Iridex's earnings per share was −$0.20 over the twelve months to Jul 4, 2026.

In its latest quarter, Q2 FY26, it was −$0.07.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.26n/a
FY2024−$0.54n/a
FY2023−$0.59n/a
FY2022−$0.47n/a
FY2021−$0.34n/a
FY2020−$0.45n/a
FY2019−$0.64n/a
FY2018−$1.06n/a
FY2017−$1.11n/a
FY2016−$1.13−3867%
FY2015$0.03−97%
FY2014$0.99+350%
FY2013$0.22+38%
FY2012$0.16−27%
FY2011$0.22−27%

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.07n/a−$0.20
Q1 FY26−$0.03n/a−$0.19
Q4 FY25−$0.01n/a−$0.26
Q3 FY25−$0.09n/a−$0.30
Q2 FY25−$0.06n/a−$0.33
Q1 FY25−$0.10n/a−$0.43
Q4 FY24−$0.05n/a−$0.54
Q3 FY24−$0.12n/a−$0.67
Q2 FY24−$0.16n/a−$0.66
Q1 FY24−$0.21n/a−$0.67
Q4 FY23−$0.18n/a−$0.59
Q3 FY23−$0.11n/a−$0.48

Against its peers

Companies in Healthcare nearest Iridex's size, closest first, today.

CompanyEPS, 12 monthsGrowth
IRIXIridex−$0.20
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Iridex

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.